Multiparametric magnetic resonance imaging (MRI) and MRI-guided prostate biopsy are emerging as useful applications in the detection of prostate cancer. Transrectal ultrasound (TRUS) biopsy, the current traditional method of diagnosis prostate cancer, can result in sampling errors that lead to delayed diagnosis or misclassification of cancers. In a first-of-its-kind trial, TRUS biopsy and MRI-guided prostate biopsy were compared to see which can best detect prostate cancers and help to triage prostate cancer patients.
Learning about dense breast tissue can help women to make more informed decisions about their health. Dense breast tissue poses a mild risk factor for developing breast cancer and can also make some cancers harder to detect on mammogram images. […]
Recent research shows that new MRI-TRUS fusion biopsy can more effectively detect high-grade prostate cancers than conventional TRUS biopsy. […]
Selective screening can help reduce mortality from abdominal aortic aneurysm among certain high-risk men aged 65 to 75. […]
Dr. Robert Princenthal will discuss benefits of and developments in MRI prostate imaging at annual conference hosted by the Prostate Cancer Research Institute. […]